Drug-labels.com

Ralivia: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) NARCOTICS (CDSA I)
Strength:
300 mg, 100 mg, 200 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Ralivia

What is RALIVIA used for?

RALIVIA (tramadol hydrochloride) is used in adults to manage moderate to severe pain. It is used when continuous treatment is required for several days or more.

How does RALIVIA work?

Serious Warnings and Precautions

  • Even if you take RALIVIA as prescribed you are at risk for opioid addiction, abuse, and misuse. This can lead to overdose and death. To understand your risk of opioid addiction, abuse, and misuse you should speak to your healthcare professional.
  • When you take RALIVIA it must be swallowed whole. Do not break, crush, chew, dissolve the tablet. This can be dangerous and can lead to death or seriously harm you.
  • You may get life-threatening breathing problems while taking RALIVIA. This is less likely to happen if you take it as prescribed by your healthcare professional. Babies are at risk of life-threatening breathing problems if their mothers take opioids while pregnant or nursing.
  • You should never give anyone your RALIVIA. They could die from taking it. If a person has not been prescribed RALIVIA, taking even one dose can cause a fatal overdose. This is especially true for children.
  • If you took RALIVIA while you were pregnant, whether for short or long periods of time or in small or large doses, your baby can suffer life-threatening withdrawal symptoms after birth. This can occur in the days after birth and for up to 4 weeks after delivery. If your baby has any of the following symptoms:

    • has changes in their breathing (such as weak, difficult or fast breathing)
    • is unusually difficult to comfort
    • has tremors (shakiness)
    • has increased stools, sneezing, yawning, vomiting, or fever

Seek immediate medical help for your baby.

  • Taking RALIVIA with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.

RALIVIA is a painkiller belonging to the class of medicines known as opioids. It relieves pain by acting on specific nerve cells of the spinal cord and brain.

What are the ingredients in RALIVIA?

Medicinal ingredients: Tramadol hydrochloride

Non-medicinal ingredients: Black Ink (Ammonium Hydroxide, Iron Oxide Black, Isopropyl Alcohol, n-Butyl Alcohol, Propylene Glycol and Shellac Glaze), Colloidal Silicon Dioxide, Ethylcellulose, Dibutyl Sebacate, Polyvinyl Alcohol, Polyvinyl Pyrrolidone, and Sodium Stearyl Fumarate.

RALIVIA comes in the following dosage forms:

Extended-release tablets: 100 mg, 200 mg and 300 mg of tramadol hydrochloride.

Do not use RALIVIA if:

  • your healthcare professional did not prescribe it for you.
  • you are allergic to tramadol hydrochloride, other opioids, or any of the other ingredients of RALIVIA.
  • your pain can be controlled by the occasional use of painkillers including those available without a prescription.
  • you have severe asthma, trouble breathing, or other breathing problems.
  • you have any heart problems.
  • you have bowel blockage or narrowing of the stomach or intestines.
  • you have severe pain in your abdomen.
  • you have increased pressure in your skull or have a head injury.
  • you have or have a history of epilepsy.
  • you have severe kidney problems.
  • you have severe liver problems.
  • you suffer from alcoholism or alcohol withdrawal.
  • you are taking or have taken within the past 2 weeks a Monoamine Oxidase inhibitor (MAOi) (such as phenelzine sulphate, tranylcypromine sulphate, moclobemide or selegiline).
  • you are less than18 years old and are having (or have recently had) your tonsils or adenoids removed because of frequent interruption of breathing during sleep.
  • you are less than 12 years old.
  • you are pregnant or plan to become pregnant, or you are in labour or delivery.
  • you are breastfeeding or plan to breastfeed.
  • you have recently taken alcohol, hypnotics, centrally acting analgesics, opioids, or psychotropic drugs. Ask your healthcare professional if you are unsure.
  • you are going to have, or recently had, a planned surgery.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take RALIVIA. Talk about any health conditions or problems you may have, including if you:

  • have a history of illicit or prescription drug or alcohol abuse.
  • have low blood pressure.
  • have past or current depression.
  • suffer from chronic or severe constipation.
  • have been told that you metabolize tramadol or other pain medications rapidly.
  • have problems with your thyroid, adrenal or prostate gland.
  • have diabetes.
  • have liver problems.
  • have kidney problems.
  • have or have had problems with your mood (such as depression or anxiety), hallucinations, or other mental health problems.
  • have or had in the past hallucinations or other severe mental problems.
  • have a central nervous system (CNS) infection.
  • are dependent on opioids.
  • are planning on drinking alcohol. Drinking alcohol while taking RALIVIA may cause dangerous side effects, including death. Do not drink alcohol while taking RALIVIA.
  • have suicidal thoughts or actions.
  • have circulatory problems (e.g., body does not get enough oxygen and nutrients to function properly due to a lack of blood flow).
  • have been told you are at risk of having heart problems, hyponatremia (low sodium levels in the blood), or seizures.
  • have a condition that causes weakness or frailty.
  • have difficulty urinating.
  • have a sleep disorder which causes pauses in breathing or shallow breathing while sleeping (sleep apnea).
  • are over 65 years of age.

Other warnings you should know about:

Taking RALIVIA can cause the following serious side effects:

  • Allergic reactions: Serious and rarely fatal allergic reactions (e.g., swelling of lips and throat, blistering of skin and/or lips or neck) have been reported in patients receiving therapy with tramadol. Seek medical attention immediately.
  • Disorder of the adrenal gland: You may develop a disorder of the adrenal gland called adrenal insufficiency. This means that your adrenal gland is not making enough of certain hormones. You may experience symptoms such as:

    • nausea, vomiting
    • feeling tired, weak or dizzy
    • decreased appetite

You may be more likely to have problems with your adrenal gland if you have been taking opioids for longer than one month. Your healthcare professional may do tests, give you another medication, and slowly take you off RALIVIA.

  • Hypoglycemia (low blood sugar): RALIVIA can decrease your blood sugar levels. Diabetic patients may need to monitor their blood sugar more often. If you notice changes, discuss this with your healthcare professional.
  • Seizure risk: Seizures have been experienced by patients taking RALIVIA at the doses prescribed. This risk may increase with higher doses.
  • Serotonin toxicity (also known as Serotonin Syndrome): RALIVIA can cause serotonin toxicity, a rare but potentially life-threatening condition. It can cause serious changes in how your brain, muscles and digestive system work. You may develop

    • -depressants or migraine medications. Serotonin toxicity symptoms include:

      • fever, sweating, shivering, diarrhea, nausea, vomiting;
      • muscle shakes, jerks, twitches or stiffness, overactive reflexes, loss of coordination;
      • fast heartbeat, changes in blood pressure;
      • confusion, agitation, restlessness, hallucinations, mood changes, unconsciousness, and coma.
  • Sleep apnea: Opioids can cause a problem called sleep apnea (stopping breathing from time to time while sleeping). Tell your healthcare professional if you have a history of sleep apnea or if anyone notices that you stop breathing from time to time while sleeping.

See the Serious side effects and what to do about them table below for more information on these and other serious side effects

Adolescents (12 to 18 years old): You should not use RALIVIA if your child:

  • is overweight (obese),
  • has obstructive sleep apnea (a condition where your breathing starts and stops while you sleep),
  • has severe lung disease.

There is a higher risk of serious breathing problems if your child takes RALIVIA and has any of the above conditions.

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to RALIVIA. RALIVIA can cause:

  • drowsiness,
  • dizziness, or
  • light-headedness

This can usually occur after the first dose and when the dose is increased.

Opioid dependence and addiction: There are important differences between physical dependence and addiction. It is important that you talk to your healthcare professional if you have questions or concerns about abuse, addiction or physical dependence.

Pregnancy, nursing, labour and delivery: Do not use RALIVIA while pregnant, nursing, during labour or delivery. Opioids can be transferred to your baby through breast milk, or while still in the womb. RALIVIA can then cause life-threatening breathing problems in your unborn baby or nursing infant.

If you are pregnant and are taking RALIVIA, it is important that you don’t stop taking your medication all of a sudden. If you do, it can cause a miscarriage or a still-birth. Your healthcare professional will monitor and guide you on how to slowly stop taking RALIVIA. This may help avoid serious harm to your unborn baby.

Sexual function and reproduction: Long term use of opioids may lead to a decrease in sex hormone levels. It may also lead to low libido (desire to have sex), erectile dysfunction or being infertile.

Testing and check-ups:

  • RALIVIA can cause abnormal blood test results including decreased blood sugar. Your healthcare professional will decide when to perform blood tests and will interpret the results.
  • Your healthcare professional will also regularly monitor you for signs of misuse and abuse.

Worsening pain: Taking opioids for pain can sometimes have the unintended effect of making your pain feel worse (opioid-induced hyperalgesia) even though your opioid dose has been unchanged or increased. This can also include feeling pain in new places in your body or feeling pain from something that would not normally hurt, for example, feeling pain from clothing touching your skin. Tell your healthcare professional if you notice a change like this in your pain while you are taking RALIVIA.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Serious Drug Interactions

Serious drug interactions with RALIVIA include:

  • benzodiazepines used to help you sleep or that help reduce anxiety.
  • central nervous system (CNS) depressants used to slow down the nervous system.

    These can include:

    • other opioids used to relieve pain (e.g., methadone);
    • hypnotics used to help with sleeping;
    • antidepressants used for depression and mood disorders (e.g., fluoxetine, citalopram, venlafaxine; tricyclic antidepressants such as amitriptyline, imipramine, maprotiline, paroxetine; serotonin norepinephrine re-uptake inhibitors [SNRIs]; and selective serotonin re-uptake inhibitors [SSRIs] such as St. John’s Wort);
    • anxiolytics, tranquilizers, and phenothiazines used to treat mental or emotional disorders;
    • muscle relaxants used to treat muscle spasms and back pain (e.g., baclofen);
    • general anaesthetics used during surgery;
    • antipsychotics and neuroleptics used to treat mental health disorders (e.g., chlorpromazine, pimozide, haloperidol, droperidol, ziprasidone, and risperidone);
    • antihistamines used to treat allergies;
    • antiemetics used to prevent nausea or vomiting (e.g., domperidone and ondansetron);
    • sedatives which may enhance the drowsiness;

      pregabalin, used to treat nerve pain;

      gabapentin, used to prevent and control seizures in the treatment of epilepsy; beta blockers used to lower blood pressure;

    • alcohol. This includes prescription and non-prescription medications that contain alcohol. Do not drink alcohol while you are taking RALIVIA. It can lead to drowsiness, usually slow or weak breathing, serious side effects, or a fatal overdose.
  • monoamine oxidase inhibitors (MAOIs) used to treat depression. Do not take RALIVIA with MAOIs or if you have taken MAOI’s in the last 14 days.

The following may interact with RALIVIA:

  • carbamazepine used to treat certain types of seizures.
  • anticoagulants used to thin the blood and prevent blood clots (e.g., warfarin).
  • antiretrovirals used to treat viral infections (e.g., ritonavir).
  • antifungals used to treat fungal infections (e.g., ketoconazole, fluconazole, and voriconazole).
  • antibiotics used to treat bacterial infections (e.g., rifampin, erythromycin, clarithromycin, azithromycin, tacrolimus, moxifloxacin, levofloxacin, ciprofloxacin, and pentamidine).
  • medicines that can affect the heart (e.g., digoxin, quinidine, procainamide, disopyramide, amiodarone, sotalol, ibutilide, dronedarone, flecainide, propafenone, sunitinib, nilotinib, ceritinib, vandetanib, salmeterol and formoterol).
  • antimalarials used to treat malaria (e.g., quinine and chloroquine).
  • medicines used to treat cancer (e.g., vorinostat and arsenic trioxide).
  • grapefruit juice.
  • medicines used to decrease electrolyte levels in the body (e.g., diuretics, laxatives, enemas, amphotericin B, high doses of corticosteroids, and proton pump inhibitors).

If you are unsure about the medications you are taking, ask your healthcare professional.

How to take RALIVIA:

  • RALIVIA must be taken orally, by mouth.
  • Take RALIVIA every 24 hours as prescribed with a glass of water. It can be taken with or without food.

  • Swallow tablet whole. Do not break, crush, chew or dissolve the tablet. This can be dangerous and can lead to death or seriously harm you.
  • Review your pain regularly with your healthcare professional to determine if you still need RALIVIA. Be sure to use RAVILIA only for the condition for which it was prescribed.

Usual Dose:

Your dose is tailored/personalized just for you, take it exactly as your healthcare professional has told you to. Do not increase or decrease your dose or stop taking RALIVIA all of a sudden without talking to your healthcare professional. Taking higher doses can lead to more side effects and a greater chance of overdose.

The usual starting dose of RALIVIA is 100 mg per day.

You should not take more than the maximum recommended dose of 300 mg of RALIVIA per day. Exceeding this recommendation can result in respiratory depression (shallow, slow breathing), seizures, coma, heart stoppage and death.

Stopping your Medication: If you have been taking RALIVIA for more than a few days you should not stop taking it all of a sudden. You should check with your healthcare professional for directions on how to slowly stop taking it. You should do it slowly to avoid uncomfortable symptoms such as:

  • body aches;
  • diarrhea;
  • gooseflesh;
  • loss of appetite;
  • nausea;
  • feeling nervous or restless;
  • runny nose;
  • sneezing;
  • tremors or shivering;
  • stomach cramps;
  • rapid heart rate (tachycardia);
  • having trouble sleeping;
  • an unusual increase in sweating;
  • an unexplained fever;
  • weakness;
  • yawning.

By reducing your dose or stopping your opioid treatment, your body will become less used to opioids. If you start treatment again, you will need to start at the lowest dose. You may overdose if you restart at the last dose you took before you reduced your dose or you stopped taking RALIVIA.

Refilling your Prescription for RALIVIA: A new written prescription is required from your healthcare professional each time you need more RALIVIA. Therefore, it is important that you contact your healthcare professional before your current supply runs out.

Only obtain prescriptions for this medicine from the healthcare professional in charge of your treatment. Do not seek prescriptions from other healthcare professionals unless you switch to another healthcare professional for your pain management.

Overdose:

Signs of overdose with RALIVIA may include:

  • unusually slow or weak breathing,
  • dizziness,
  • confusion,
  • extreme drowsiness,
  • fits (seizures),
  • irritation and discomfort in the stomach and gut,
  • nausea,
  • vomiting,
  • feeling unwell,
  • pale color and sweating,
  • toxic leukoencephalopathy (a brain disorder affecting the brain’s white matter),
  • QT prolongation (abnormal electrical activity in the heart),
  • lack of muscle shape and tone,
  • cold and clammy skin,
  • shrinking of pupils,
  • slow heart rate,
  • low blood pressure.
If you think you, or a person you are caring for, have taken too much RALIVIA, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

It is very important that you do not miss taking your dose. If you miss one dose, skip the missed dose and take your next dose as scheduled. Do not take two doses at once to make up for a missed dose. If you miss several doses in a row, talk to your healthcare professional before restarting your medication.

What are possible side effects from using RALIVIA?

These are not all the possible side effects you may feel when taking RALIVIA. If you experience any side effects not listed here, tell your healthcare professional.

Side effects may include:

  • drowsiness
  • insomnia
  • dizziness
  • fainting
  • nausea, vomiting, poor appetite
  • dry mouth
  • headache
  • problems with vision
  • weakness, uncoordinated muscle movement
  • itching
  • sweating
  • constipation. Talk with your healthcare professional about ways to prevent constipation when you start using RALIVIA.
  • low sex drive, impotence (erectile dysfunction), infertility

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
UNCOMMON
Hypoglycemia (low blood sugar levels): dizziness, lack of energy, drowsiness, headache, trembling, sweating.√
RARE
Overdose: hallucinations, confusion, inability to walk normally, slow or weak breathing, extreme sleepiness, sedation, or dizziness, floppy muscles/low muscle tone, cold and clammy skin.√

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Respiratory depression:

Slow, shallow or weak breathing.

√
Allergic reaction: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing.√

Bowel blockage (impaction):

abdominal pain, severe constipation, nausea.

√
Withdrawal: nausea, vomiting, diarrhea, anxiety, shivering, cold and clammy skin, body aches, loss of appetite, sweating.√
Fast, slow or irregular Heartbeat: heart palpitations.√
Hypotension (low blood pressure): dizziness, fainting, light-headedness.√
Serotonin toxicity (also known as serotonin syndrome): a reaction which may cause feelings of agitation or restlessness, flushing, muscle twitching, involuntary eye movements, heavy sweating, high body temperature (>38°C ), or rigid muscles.√
UNKNOWN
Hallucinations: seeing or hearing things that are not there.√
Disorders of the adrenal gland: nausea, vomiting, anorexia, fatigue, weakness, dizziness, or low blood pressure.√
Sleep apnea: stop breathing for short periods during your normal nightly sleep.√

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Seizures (fit): uncontrollable shaking with or without loss of consciousness.
√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Store RALIVIA at room temperature (15-30ºC) in tightly closed container. Protect from light, moisture and humidity.
  • Keep unused or expired RALIVIA in a secure place to prevent theft, misuse or accidental exposure.
  • Keep RALIVIA out of sight and reach of children and pets.
  • Accidental overdose with RALIVIA by a child is dangerous and may result in death.
  • Do not give any of it to anyone other than the person for whom it was prescribed, since it may seriously harm them.
  • Never take medicine in front of small children as they will want to copy you. Accidental ingestion by a child is dangerous and may result in death. If a child accidently takes RALIVIA, get emergency help right away.
  • RALIVIA should never be thrown into household trash, where children and pets may find it. It should be returned to a pharmacy for proper disposal.

If you want more information about RALIVIA:

  • Talk to your healthcare professional
  • Find the full Product Monograph that is prepared for healthcare professionals and includes

    • Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website www.bauschhealth.ca, or by calling 1-800-361-4261.

Bausch Health, Canada Inc.

2150 St-Elzear Blvd., West

Laval, QC, H7L 4A8

www.bauschhealth.ca

Last Revised: FEB 11, 2025

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02299216

Revision date stated in the text: February 11, 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ralivia

Rx or OTC
Prescription (Rx)?
DIN 02299216, 02299194, 02299208
Schedule(s) NARCOTICS (CDSA I)
Risk Management Plans A Canadian Specific Opioid targeted Risk Management Plan (CSO-tRMP) for this product was submitted.
Active ingredient(s) Tramadol hydrochloride
Dosage form(s) Tablet (Extended-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02A Opioid analgesics
        1. N02AX Other opioids
          1. N02AX02 Tramadol
Company BAUSCH HEALTH, CANADA INC.
Current status Marketed
Current status date June 25, 2021
Strengths and forms
DIN Strength Dosage form(s) Current status
02299216 300 MG Tablet (Extended-Release) Marketed June 25, 2021
02299194 100 MG Tablet (Extended-Release) Marketed June 25, 2021
02299208 200 MG Tablet (Extended-Release) Marketed June 25, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.